A new formula for evaluating culprit lesion characteristics in STEMI patients based on baseline

基于基线数据评估STEMI患者罪犯病变特征的新公式

阅读:1

Abstract

BACKGROUND: Acute myocardial infarction is a leading cause of death worldwide. ST-segment elevated myocardial infarction patients exhibit different plaque morphology depending on many factors. However, the development of pathological states should not be attributed to a single factor alone. Therefore, a new formula is needed to comprehensively predict plaque characteristics to improve patient risk stratification and enable precision management. METHODS: This study include patients first diagnosed ST-segment elevation myocardial infarction who underwent optical coherence tomography before the intervention. NGSA2/P2 = ln ((non-high-density lipoprotein cholesterol / high-density lipoprotein cholesterol)*Glycosylated hemoglobin * admission systolic blood pressure * (Age)(2)/(platelet count)(2)) and further divided into three groups, T0 (<4.315), T1(≥4.315, <5.340), T3(≥5.340). RESULTS: A total of 268 patients were analyzed. Compared to the plaque erosion patients, the plaque rupture patients were older, had lower platelet counts, a higher prevalence of multi-vessel disease, and significantly higher levels of NGSA2/P2. Plaque rupture was positively correlated with age and NGSA2/P2 values, and negatively correlated with platelet counts. Compared to T0 group, the T1 and T2 groups had more cholesterol crystals, macrophages, thin-cap fibroatheromas, smaller normal°, greater lipid-rich° and lipid core index. CONCLUSIONS: The new formula NGSA2/P2 integrates multiple indicators and provides superior predictions of plaque characters compared to the observation single factor. For older patients, it may be particularly important to strengthen the regulation of lipids, blood pressure, blood glucose, and platelet counts.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。